Advanced in Nerve Decompression

Dr. Peter A. Crisologo

Podiatric Medicine
University Of Texas Southwestern Medical Center At Dallas
5200 Harry Hines Blvd, 
Dallas, TX 
Advanced in Nerve Decompression
University Of Texas Southwestern Medical Center At Dallas
5200 Harry Hines Blvd, 
Dallas, TX 
OverviewInsuranceLocationsClinical Research

Overview

Peter Crisologo is a Podiatric Medicine provider in Dallas, Texas. Dr. Crisologo is rated as an Advanced provider by MediFind in Nerve Decompression. His top areas of expertise are Gangrene, Boils, Fungal Nail Infection, Nerve Decompression, and Tissue Biopsy.

His clinical research consists of co-authoring 51 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Specialties
Podiatric Medicine
Licenses
Podiatrist in OH
Hospital Affiliations
Parkland Health & Hospital System
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medical Card System
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
5200 Harry Hines Blvd, Dallas, TX 75235

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open Label, Controlled, Phase 2, Multi-Center Study to Assess Safety, Tolerability and Efficacy of Adjunctive Treatment With Topically Applied MBN-101 (Pravibismane Topical Suspension) in Subjects With Moderate Diabetic Foot Infection (DFI)
A Randomized, Open Label, Controlled, Phase 2, Multi-Center Study to Assess Safety, Tolerability and Efficacy of Adjunctive Treatment With Topically Applied MBN-101 (Pravibismane Topical Suspension) in Subjects With Moderate Diabetic Foot Infection (DFI)
Enrollment Status: Completed
Publish Date: November 04, 2024
Intervention Type: Drug, Other
Study Drug: Topical Pravibismane
Study Phase: Phase 2

51 Total Publications

Diabetic Foot Infections.
Diabetic Foot Infections.
Journal: Infectious disease clinics of North America
Published: April 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Crisologo's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile